MIH
GSK icon

Meitav Investment House’s GSK GSK Stock Holding History

Meitav Investment House’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,440
Closed -$622K – 415
2020
Q4 		$622K Buy
13,440
+6,240
+87% +$287K 0.02% 246
2020
Q3 		$337K Buy
7,200
+3,040
+73% +$152K 0.02% 311
2020
Q2 		$212K Buy
+4,160
New +$213K 0.01% 360
2020
Q1 		– Sell
-4,000
Closed -$235K – 409
2019
Q4 		$235K Hold
4,000
– – 0.02% 373
2019
Q3 		$207K Hold
4,000
– – 0.01% 412
2019
Q2 		$200K Buy
+4,000
New +$201K 0.01% 405

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Meitav Investment House's GSK Position: Q1 2021 in Review

Meitav Investment House sold out of GSK (GSK) in Q1 2021, closing a stake of 13,440 shares — an estimated $622K sold.

Meitav Investment House first reported a position in GSK in Q2 2019 and held it in 6 quarters. The position peaked at $622K in Q4 2020. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

  • Meitav Investment House reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
  • Meitav Investment House sold 13,440 GSK shares in Q1 2021, an estimated $622K.
  • Meitav Investment House first reported a position in GSK in Q2 2019 and held it in 6 quarters.
  • Meitav Investment House's GSK position peaked at $622K in Q4 2020.
  • 774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Meitav Investment House's 13F filing for Q1 2021, filed 6 May 2021.